VULTAGGIO VINCENT (PAO and PFO) sold 21.5% of their position (40.22K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $97.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/10/2026ACC: 0002018766-26-000006
Officer· PAO and PFO
Since Feb 2026
-40.22K
Net shares
Net seller
$97.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
40.22K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−29.95K
Price / share
$2.43
Trade value
$72.77K
% of position
16.0%
2/6/2026
186.73K→156.78K
Common Stock
Direct
Shares
−3.38K
Price / share
$2.39
Trade value
$8.09K
% of position
2.2%
2/9/2026
156.78K→153.40K
Common Stock
Direct
Shares
−6.89K
Price / share
$2.42
Trade value
$16.70K
% of position
4.5%
2/10/2026
153.40K→146.51K
Total
Net shares
−40.22K
Net value
-$97.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | S · Sale | −29.95K | $2.43 | $72.77K | 16.0% | 186.73K | 156.78K |
| Common Stock Direct | 2/9/2026 | S · Sale | −3.38K | $2.39 | $8.09K | 2.2% | 156.78K | 153.40K |
| Common Stock Direct | 2/10/2026 | S · Sale | −6.89K | $2.42 | $16.70K | 4.5% | 153.40K | 146.51K |
| Total | −40.22K | -$97.56K | ||||||
Derivative Transactions0
No derivative transactions reported